Physician profile
Mantu Gupta
NPI 1114981370
$229,491.30
in general payments reported to CMS, 2019-2025
35 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $18K · 2021: $38K · 2022: $36K · 2023: $63K · 2024: $29K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $90K · Consulting Fee: $9,190 · Food and Beverage: $7,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $89,953.00 |
| Consulting Fee | $9,190.00 |
| Food and Beverage | $7,191.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $159,986.26 | 2019-2025 | General - Kidney Stone Disease, Lithovue, General - Therapies |
| Olympus America INC. | $42,295.78 | 2019-2024 | Soltive, Soltive |
| Lumenis, INC | $7,157.77 | 2020-2021 | |
| Travere Therapeutics, INC. | $6,987.13 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $6,098.01 | 2020-2025 | Oxlumo |
| Lumenis LTD. | $2,000.00 | 2021 | |
| Olympus Winter & Ibe Gmbh | $1,080.00 | 2024 | Single Use Repositionable Clip |
| Olympus Corporation of The Americas | $871.17 | 2021-2022 | |
| Olympus Corporation | $540.00 | 2022 | |
| Coloplast Corp | $312.44 | 2019-2025 | |
| Procept Biorobotics Corporation | $302.75 | 2021-2025 | |
| Calyxo, INC. | $254.73 | 2023-2024 | Cvac Aspiration System |
| Urogen Pharma, INC. | $231.71 | 2022-2023 | Jelmyto |
| Myovant Sciences INC. | $146.49 | 2022 | |
| Gyrus Acmi, INC. | $134.08 | 2025 | Soltive |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Micro-Tech Endoscopy USA, INC. | $132.61 | 2022 | |
| Ambu INC. | $120.84 | 2025 | |
| Ferring Pharmaceuticals INC. | $116.86 | 2025 | Adstiladrin |
| Novo Nordisk Health Care Ag | $114.09 | 2024 | |
| Merck Sharp & Dohme LLC | $80.53 | 2021-2023 | Lynparza, Keytruda |
| Pfizer INC. | $72.68 | 2019-2022 | |
| Novo Nordisk INC | $57.79 | 2024-2025 | Rivfloza |
| Sumitomo Pharma America, INC. | $56.07 | 2024-2025 | Orgovyx |
| Abbvie INC. | $50.15 | 2023 | |
| Rochester Medical Corporation | $45.18 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $34.36 | 2022 | |
| Novartis Pharmaceuticals Corporation | $29.91 | 2023 | |
| Hollister Incorporated | $27.16 | 2023 | Infyna Chic, Vapro Pocket, Vapro |
| Progenics Pharmaceuticals, INC. | $26.90 | 2021 | |
| Blue Earth Diagnostics | $26.52 | 2019 | |
| Gilead Sciences, INC. | $26.51 | 2025 | |
| Astellas Pharma US INC | $24.00 | 2022 | |
| Abiomed | $18.71 | 2021 | |
| 180 Medical, INC. | $16.62 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $15.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mantu Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.